🔧На сайте запланированы технические работы
25.12.2025 в промежутке с 18:00 до 21:00 по Московскому времени (GMT+3) на сайте будут проводиться плановые технические работы. Возможны перебои с доступом к сайту. Приносим извинения за временные неудобства. Благодарим за понимание!
🔧Site maintenance is scheduled.
Scheduled maintenance will be performed on the site from 6:00 PM to 9:00 PM Moscow time (GMT+3) on December 25, 2025. Site access may be interrupted. We apologize for the inconvenience. Thank you for your understanding!

 

Phospholipase A2 Inhibitors Modulate the Effect of Trifluoperazine on the Intracellular Ca2+ Concentration in Macrophages


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Using Fura-2AM microfluorimetry, it was shown for the first time that phospholipase A2 inhibitors 4-bromophenacyl bromide and glucocorticosteroids prednisolone and dexamethasone attenuate Ca2+ responses induced by neuroleptic trifluoperazine in macrophages. The results suggest the involvement of phospholipase A2 and arachidonic acid metabolism cascade in the effect of trifluoperazine on intracellular Ca2+ concentration in macrophages.

Sobre autores

Z. Krutetskaya

St. Petersburg State University

Autor responsável pela correspondência
Email: z.krutetskaya@spbu.ru
Rússia, St. Petersburg, 199034

L. Milenina

St. Petersburg State University

Email: z.krutetskaya@spbu.ru
Rússia, St. Petersburg, 199034

A. Naumova

St. Petersburg State University

Email: z.krutetskaya@spbu.ru
Rússia, St. Petersburg, 199034

S. Butov

St. Petersburg State University

Email: z.krutetskaya@spbu.ru
Rússia, St. Petersburg, 199034

V. Antonov

St. Petersburg State University

Email: z.krutetskaya@spbu.ru
Rússia, St. Petersburg, 199034

A. Nozdrachev

St. Petersburg State University

Email: z.krutetskaya@spbu.ru
Rússia, St. Petersburg, 199034

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Ltd., 2018